Excelsior BioPharma Inc.

Excelsior BioPharma Inc. is a Taiwan-based pharmaceutical and biotechnology company specializing in the research, development, manufacture, and distribution of a diverse range of healthcare products. Its primary function is to address both mainstream and rare diseases through innovative prescription medicines, specialty drugs for complex medical conditions, antidotes, diagnostic test reagents, and oral care products. The company supports end-to-end commercialization in the biopharma sector, from diagnostic support via its in-house laboratory to navigating regulatory approval and executing market access strategies, especially within Taiwan and Southeast Asia. Excelsior BioPharma Inc. actively engages with hospitals, key opinion leaders, and healthcare networks, serving as a strategic partner for international firms aiming to enter regional markets. Established in 1988 and headquartered in Taipei, the company plays a significant role in the health technology industry by providing both domestic and international distribution of essential medical products, contributing to improved healthcare by combining R&D capabilities with strong operational infrastructure.